Physician profile
Neel Patel
NPI 1740695212
$23,649.03
in general payments reported to CMS, 2019-2025
21 companies · $15K in 2025
The $15K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.67 · 2020: $362 · 2021: $295 · 2022: $2,461 · 2023: $1,713 · 2024: $3,879 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $4,024 · Food and Beverage: $3,371 · Gift: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,625.00 |
| Travel and Lodging | $4,023.84 |
| Food and Beverage | $3,371.24 |
| Gift | $489.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Total Joint Orthopedics, INC. | $14,543.95 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $5,848.46 | 2022-2025 | Persona, Comprehensive Shoulder System, Avenir |
| Cdc Medical LLC | $1,215.60 | 2022-2023 | |
| Stryker Corporation | $321.06 | 2020-2025 | Mako |
| Medtronic USA, INC. | $300.49 | 2020 | |
| Si-Bone, INC. | $216.73 | 2021 | |
| Medinc of Texas | $146.07 | 2023 | |
| Omnilife Science, INC | $139.86 | 2024-2025 | Various Products |
| Encore Medical, LP | $135.72 | 2025 | Djo Surgical |
| Depuy Synthes Sales INC. | $111.49 | 2023-2025 | Attune, Na, Truespan Orthocord |
| Osteoremedies, LLC | $103.66 | 2025 | Remedy Spectrum Gv Spacer, Biobrush, Biowash Surgical Irrigation |
| Onkos Surgical, INC. | $78.22 | 2025 | Eleos Limb Salvage System |
| Biocomposites INC | $76.92 | 2023 | Stimulan |
| Amgen INC. | $72.82 | 2025 | |
| Sanara Medtech INC. | $68.13 | 2025 | Celleraterx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $63.99 | 2022-2025 | Real Intelligence, Tandem, Legion Revision |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Aesculap Implant Systems, LLC | $35.56 | 2020 | |
| Medtronic, INC. | $35.00 | 2025 | Aquamantys(Tm) |
| Merck Sharp & Dohme LLC | $31.12 | 2024 | Bridion |
| E.R. Squibb & Sons, L.L.C. | $20.06 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.